FDA approved dasatinib (SPRYCEL, Bristol-Myers Squibb Co.) for treatment of pediatric patients suffering from Philad…https://t.co/RE8ebUwDwq
— Domanique Culpepper (@DomCulpepper) November 13, 2017
from Twitter https://twitter.com/DomCulpepper
November 13, 2017 at 10:39AM
via IFTTT
No comments:
Post a Comment